Online CME: Parkinson's Disease

The Future of Parkinson’s Disease: Diagnosis and Management

Credits: 1.00

Fee: None

Expires: Not Listed

Multimedia: None

Complete this program to review neuroprotective treatment strategies for Parkinson’s disease, the neuroprotective effects of dopaminergic therapies that are currently available, emerging therapies for treating both motor and non-motor symptoms of Parkinson’s disease, drug delivery advances, the “unmet need for valid rating scales to identify early nonmotor symptoms of PD,” and potential biomarkers for aiding in early Parkinson’s disease diagnosis.

Click here to access this third-party resource

Strategies for Parkinson’s Disease Care: Evolving Approaches to Initial and Combination Therapy with Monoamine Oxidase Inhibitors

Credits: 1.00

Fee: None

Expires: Not Listed

Multimedia: None

The mechanism of action of MAO-B inhibitors and why these agents are a good choice for initial monotherapy in patients with Parkinson’s disease; their role as adjunct therapy with levodopa in patients with advanced disease who experience motor fluctuations and dyskinesia; the differences in efficacy, safety, and tolerability profiles of rasagiline and selegiline; and the “potential neuroprotective effect of MAO-B inhibitors in animal models of PD” form the foci of this course.

Click here to access this third-party resource